Lv1
60 积分 2025-08-15 加入
Linker Chemistry in Antibody–Drug Conjugates: Current Strategies, Clinical Pharmacokinetic Analyses, and Linker-Free Outlooks
1天前
待确认
Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody–Drug Conjugates (ADCs)
7天前
已完结
Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers
7天前
已完结
Antibody–drug conjugates come of age in oncology
3个月前
已完结
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries
3个月前
已完结
Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain‐Mediated Metabolite Formation
3个月前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
3个月前
已完结
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
4个月前
已完结
The structural basis of camptothecin interactions with human serum albumin: impact on drug stability
4个月前
已完结
Current State of the Art in HPLC Methodology for Lipophilicity Assessment of Basic Drugs. A Review
4个月前
已完结
皖公网安备34019202002308
